Near-Patient Molecular Solutions MarketNear-Patient Molecular Solutions Market By Product Type (Infectious diseases testing kits, Urinalysis testing kits, Tumor/cancer markers, Pregnancy and fertility, Hematology testing kits, Glucose monitoring kits, Drugs-of-abuse testing kits, Coagulation monitoring kits, Cardiometabolic monitoring kits, and Others), By Technology (PCR-based, Microarray-based, Hybridization-based, and Genetic sequencing based), By End-user (Hospitals, Research Laboratories, Homecare, and Diagnostic Laboratories), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Published date: Oct 2025
Report ID: 162285
Number of Pages: 334
Format:

Fact Checked

Cite this Research

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
  - 1.8. Industry Voices
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Near-Patient Molecular Solutions Market Trends
  - 2.3. Technology Landscape
  - 2.4. Regulatory Framework
  - 2.5. Sustainability and ESG (Environmental, Social, Governance)
  - 2.6. Opportunity Map Analysis
  - 2.7. Opportunity Orbits
  - 2.8. PESTLE Analysis
  - 2.9. PORTER’S Five Force Analysis
  - 2.10. Drivers & Restraints Impact Analysis
  - 2.11. Value Chain Analysis
    
    2.11.1. List of Raw Materials Suppliers
    
    2.11.2. List of Near-Patient Molecular Solutions Manufacturers
    
    2.11.3. List of Dealer/Distributors
  - 2.12. Regional Market Share and BPS Analysis
  - 2.13. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Near-Patient Molecular Solutions Market Analysis and Forecast, By Segment, 2020-2034
  - 3.1. Key Findings
  - 3.2. Global Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 3.3. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
    
    3.3.1. Infectious diseases testing kits
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Urinalysis testing kits
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
    
    3.3.3. Tumor/cancer markers
    
    3.3.3.1. Insights
    
    3.3.3.2. Key Takeaways
    
    3.3.4. Pregnancy and fertility
    
    3.3.4.1. Insights
    
    3.3.4.2. Key Takeaways
    
    3.3.5. Hematology testing kits
    
    3.3.5.1. Insights
    
    3.3.5.2. Key Takeaways
    
    3.3.6. Glucose monitoring kits
    
    3.3.6.1. Insights
    
    3.3.6.2. Key Takeaways
    
    3.3.7. Drugs-of-abuse testing kits
    
    3.3.7.1. Insights
    
    3.3.7.2. Key Takeaways
    
    3.3.8. Coagulation monitoring kits
    
    3.3.8.1. Insights
    
    3.3.8.2. Key Takeaways
    
    3.3.9. Cardiometabolic monitoring kits
    
    3.3.9.1. Insights
    
    3.3.9.2. Key Takeaways
    
    3.3.10. Others
    
    3.3.10.1. Insights
    
    3.3.10.2. Key Takeaways
  - 3.4. Global Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  - 3.5. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
    
    3.5.1. PCR-based
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Microarray-based
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Hybridization-based
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Genetic sequencing-based
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
  - 3.6. Global Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 3.7. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
    
    3.7.1. Hospitals
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Research laboratories
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Homecare
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
    
    3.7.4. Diagnostic laboratories
    
    3.7.4.1. Insights
    
    3.7.4.2. Key Takeaways
- 4. Global Near-Patient Molecular Solutions Market Analysis and Forecast, By Region, 2020-2034
  - 4.1. Key Findings
  - 4.2. Global Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Region
- 5. North America Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
  - 5.1. Key Findings
  - 5.2. North America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 5.3. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - 5.4. North America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  - 5.5. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - 5.6. North America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 5.7. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - 5.8. North America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 5.9. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
    
    5.9.1. The US
    
    5.9.2. Canada
- 6. Europe Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
  - 6.1. Key Findings
  - 6.2. Europe Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 6.3. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - 6.4. Europe Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  - 6.5. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - 6.6. Europe Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 6.7. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - 6.8. Europe Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 6.9. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
    
    6.9.1. Germany
    
    6.9.2. The UK
    
    6.9.3. France
    
    6.9.4. Spain
    
    6.9.5. Italy
    
    6.9.6. Russia
    
    6.9.7. Netherland
    
    6.9.8. Rest of Europe
- 7. Asia Pacific Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
  - 7.1. Key Findings
  - 7.2. Asia Pacific Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 7.3. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - 7.4. Asia Pacific Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  - 7.5. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - 7.6. Asia Pacific Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 7.7. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - 7.8. Asia Pacific Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 7.9. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
    
    7.9.1. China
    
    7.9.2. Japan
    
    7.9.3. South Korea
    
    7.9.4. India
    
    7.9.5. Australia
    
    7.9.6. New Zealand
    
    7.9.7. Singapore
    
    7.9.8. Thailand
    
    7.9.9. Vietnam
    
    7.9.10. Rest of Asia Pacific
- 8. Latin America Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
  - 8.1. Key Findings
  - 8.2. Latin America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 8.3. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - 8.4. Latin America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  - 8.5. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - 8.6. Latin America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 8.7. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - 8.8. Latin America Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 8.9. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
    
    8.9.1. Brazil
    
    8.9.2. Mexico
    
    8.9.3. Rest of Latin America
- 9. Middle East & Africa Near-Patient Molecular Solutions Market Analysis and Forecast, 2020-2034
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  - 9.3. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - 9.4. Middle East & Africa Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
  - 9.5. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - 9.6. Middle East & Africa Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  - 9.7. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - 9.8. Middle East & Africa Near-Patient Molecular Solutions Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 9.9. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
    
    9.9.1. South Africa
    
    9.9.2. Saudi Arabia
    
    9.9.3. UAE
    
    9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Thermo Fisher Scientific
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Siemens Healthineers
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Roche Diagnostics
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. QIAGEN N.V.
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. PerkinElmer
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Illumina, Inc.
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Cepheid (a Danaher company)
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Bio-Rad Laboratories
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Becton, Dickinson and Company (BD)
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Abbott Laboratories
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 2. Global Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 3. Global Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 4. Global Near-Patient Molecular Solutions Market Value (US$ Mn), By Region, 2020-2034
  - Table 5. North America Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 6. North America Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 7. North America Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 8. North America Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
  - Table 9. The US Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 10. The US Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 11. The US Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 12. Canada Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 13. Canada Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 14. Canada Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 15. Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 16. Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 17. Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 18. Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
  - Table 19. Germany Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 20. Germany Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 21. Germany Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 22. The UK Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 23. The UK Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 24. The UK Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 25. France Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 26. France Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 27. France Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 28. Spain Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 29. Spain Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 30. Spain Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 31. Italy Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 32. Italy Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 33. Italy Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 34. Russia Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 35. Russia Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 36. Russia Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 37. Netherland Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 38. Netherland Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 39. Netherland Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 40. Rest of Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 41. Rest of Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 42. Rest of Europe Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 43. Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 44. Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 45. Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 46. Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
  - Table 47. China Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 48. China Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 49. China Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 50. India Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 51. India Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 52. India Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 53. Japan Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 54. Japan Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 55. Japan Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 56. South Korea Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 57. South Korea Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 58. South Korea Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 59. Australia Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 60. Australia Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 61. Australia Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 62. New Zealand Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 63. New Zealand Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 64. New Zealand Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 65. Singapore Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 66. Singapore Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 67. Singapore Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 68. Thailand Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 69. Thailand Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 70. Thailand Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 71. Vietnam Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 72. Vietnam Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 73. Vietnam Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 74. Rest of Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 75. Rest of Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 76. Rest of Asia Pacific Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 77. Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 78. Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 79. Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 80. Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
  - Table 81. Brazil Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 82. Brazil Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 83. Brazil Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 84. Mexico Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 85. Mexico Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 86. Mexico Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 87. Rest of Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 88. Rest of Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 89. Rest of Latin America Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 90. Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 91. Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 92. Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 93. Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Country, 2020-2034
  - Table 94. South Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 95. South Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 96. South Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 97. Saudi Arabia Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 98. Saudi Arabia Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 99. Saudi Arabia Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 100. UAE Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 101. UAE Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 102. UAE Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
  - Table 103. Rest of Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Product Type, 2020-2034
  - Table 104. Rest of Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By Technology, 2020-2034
  - Table 105. Rest of Middle East & Africa Near-Patient Molecular Solutions Market Value (US$ Mn), By End-user, 2020-2034
- List of Figures
  - Figure 1. Global Near-Patient Molecular Solutions Market Snapshot: Market Value (US$ Mn), 2020-2034
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Near-Patient Molecular Solutions Market
  - Figure 5. Global Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 6. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - Figure 7. Global Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
  - Figure 8. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - Figure 9. Global Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 10. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - Figure 11. Global Near-Patient Molecular Solutions Market Analysis, By Region, 2020, 2024 and 2034
  - Figure 12. Global Near-Patient Molecular Solutions Market Attractiveness Analysis, By Region
  - Figure 13. North America Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 14. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - Figure 15. North America Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
  - Figure 16. North America Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
  - Figure 17. North America Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
  - Figure 18. North America Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
  - Figure 19. North America Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
  - Figure 20. North America Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
  - Figure 21. North America Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
  - Figure 22. North America Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
  - Figure 23. North America Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
  - Figure 24. North America Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
  - Figure 25. North America Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
  - Figure 26. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - Figure 27. North America Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
  - Figure 28. North America Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
  - Figure 29. North America Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
  - Figure 30. North America Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
  - Figure 31. North America Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 32. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - Figure 33. North America Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 34. North America Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
  - Figure 35. North America Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
  - Figure 36. North America Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
  - Figure 37. North America Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 38. North America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
  - Figure 39. Europe Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 40. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - Figure 41. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
  - Figure 42. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
  - Figure 43. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
  - Figure 44. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
  - Figure 45. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
  - Figure 46. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
  - Figure 47. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
  - Figure 48. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
  - Figure 49. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
  - Figure 50. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
  - Figure 51. Europe Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
  - Figure 52. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - Figure 53. Europe Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
  - Figure 54. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
  - Figure 55. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
  - Figure 56. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
  - Figure 57. Europe Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 58. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - Figure 59. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 60. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
  - Figure 61. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
  - Figure 62. Europe Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
  - Figure 63. Europe Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 64. Europe Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
  - Figure 65. Asia Pacific Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 66. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - Figure 67. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
  - Figure 68. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
  - Figure 69. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
  - Figure 70. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
  - Figure 71. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
  - Figure 72. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
  - Figure 73. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
  - Figure 74. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
  - Figure 75. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
  - Figure 76. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
  - Figure 77. Asia Pacific Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
  - Figure 78. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - Figure 79. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
  - Figure 80. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
  - Figure 81. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
  - Figure 82. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
  - Figure 83. Asia Pacific Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 84. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - Figure 85. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 86. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
  - Figure 87. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
  - Figure 88. Asia Pacific Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
  - Figure 89. Asia Pacific Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 90. Asia Pacific Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
  - Figure 91. Latin America Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 92. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - Figure 93. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
  - Figure 94. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
  - Figure 95. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
  - Figure 96. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
  - Figure 97. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
  - Figure 98. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
  - Figure 99. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
  - Figure 100. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
  - Figure 101. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
  - Figure 102. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
  - Figure 103. Latin America Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
  - Figure 104. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - Figure 105. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
  - Figure 106. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
  - Figure 107. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
  - Figure 108. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
  - Figure 109. Latin America Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 110. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - Figure 111. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 112. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
  - Figure 113. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
  - Figure 114. Latin America Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
  - Figure 115. Latin America Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 116. Latin America Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
  - Figure 117. Middle East & Africa Near-Patient Molecular Solutions Market Analysis, By Product Type, 2020, 2024 and 2034
  - Figure 118. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Product Type
  - Figure 119. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Infectious diseases testing kits, 2020-2034
  - Figure 120. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Urinalysis testing kits, 2020-2034
  - Figure 121. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Tumor/cancer markers, 2020-2034
  - Figure 122. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Pregnancy and fertility, 2020-2034
  - Figure 123. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Hematology testing kits, 2020-2034
  - Figure 124. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Glucose monitoring kits, 2020-2034
  - Figure 125. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Drugs-of-abuse testing kits, 2020-2034
  - Figure 126. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Coagulation monitoring kits, 2020-2034
  - Figure 127. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Cardiometabolic monitoring kits, 2020-2034
  - Figure 128. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Others, 2020-2034
  - Figure 129. Middle East & Africa Near-Patient Molecular Solutions Market Analysis, By Technology, 2020, 2024 and 2034
  - Figure 130. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Technology
  - Figure 131. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by PCR-based, 2020-2034
  - Figure 132. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Microarray-based, 2020-2034
  - Figure 133. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Hybridization-based, 2020-2034
  - Figure 134. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Genetic sequencing-based, 2020-2034
  - Figure 135. Middle East & Africa Near-Patient Molecular Solutions Market Analysis, By End-user, 2020, 2024 and 2034
  - Figure 136. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By End-user
  - Figure 137. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Hospitals, 2020-2034
  - Figure 138. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Research laboratories, 2020-2034
  - Figure 139. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Homecare, 2020-2034
  - Figure 140. Middle East & Africa Near-Patient Molecular Solutions Market (US$ Mn), by Diagnostic laboratories, 2020-2034
  - Figure 141. Middle East & Africa Near-Patient Molecular Solutions Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 142. Middle East & Africa Near-Patient Molecular Solutions Market Attractiveness Analysis, By Country
- Thermo Fisher Scientific
- Siemens Healthineers
- Roche Diagnostics
- QIAGEN N.V.
- PerkinElmer
- Illumina, Inc.
- Cepheid (a Danaher company)
- Bio-Rad Laboratories
- Becton, Dickinson and Company (BD)
- Abbott Laboratories